poisar

Stocks · News reference

Reported Earlier, Moderna To Replace Warner Bros. Discovery In Nasdaq-100 Index Before Market Open On October 9, 2026

Benzinga Newsdesk
More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

MRNAWBD
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  2. Brendan Coffey

    Novo Nordisk vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?

    Novo Nordisk and Pfizer are compared as pharmaceutical giants navigating different challenges. Novo Nordisk boasts superior profitability with a 33% net margin and strong cash flow, but faces pricing pressures and competition in the GLP-1 weight-loss drug market. Pfizer trades at lower valuations and is improving net income through strategic acquisitions in oncology and obesity, though it faces significant patent cliffs through 2030. The article recommends Pfizer as the better buy in 2026 based on its value metrics and improving earnings trajectory.

    NVOPFELLYMRNA
  3. Evette Mitkov

    Moderna Stock Is Trending: What's Going On?

    Moderna Inc (NASDAQ:MRNA) shares are trending Thursday as the stock continues working through volatility following a bearish Citi downgrade earlier this week.

    MRNA
  5. Jeremy Bowman

    Paramount and Warner Bros. Discovery to Merge Into Skydance (SKYD). Will Skydance Achieve David Ellison’s “Quality Storytelling” Vision?

    Paramount Skydance and Warner Bros. Discovery have completed their merger to form Skydance, set to close on October 6, 2026. However, the new company faces significant headwinds including an $80 billion debt burden, industry opposition from creators, settlement-imposed constraints on film production and studio operations, and a poor historical track record for large media mergers.

    PSKYWBDNFLXDIS